Core Viewpoint - The improvement in the pattern of disperse dye intermediates is expected to drive up disperse dye prices, while the supply tightening of H-acid, an active dye intermediate, may also lead to potential price increases. The price increase expectations for these two types of dyes have been gradually confirmed by leading companies' price hikes, with a positive outlook for a long-term bullish market driven by environmental and dual-carbon policies in China [1]. Industry Restructuring - China is the largest dye producer globally, but the dye industry is highly polluting, generating significant wastewater. The tightening of environmental regulations has led to the exit of non-compliant small enterprises, resulting in a higher industry concentration. The concentration ratio (CR4) for disperse dyes is 67.2%, and for active dyes, it is 65.3%, indicating a well-established industry reshuffle [1][2]. - The Ministry of Industry and Information Technology has issued guidelines to expand zero-carbon factory construction to various sectors, including textiles, which may tighten carbon emission requirements in the dyeing industry [1]. Intermediate Supply Dynamics - The production of disperse dye intermediates involves complex processes that generate substantial waste, leading to a concentrated supply among compliant enterprises in the Yangtze River Delta. The supply elasticity is low due to the closure of many non-compliant small factories [2]. - The effective capacity of H-acid has fallen below 60,000 tons, with a supply gap exceeding 10%. Recent maintenance by two major H-acid manufacturers may further reduce effective capacity by over 25% [2]. Price Elasticity and Market Comparison - The current situation of intermediates in the dye industry is likened to the relationship between citral and VA, characterized by complex synthesis processes and high concentration among leading firms. The cost of intermediates constitutes a significant portion of the production costs for dyes, which may lead to effective cost transmission [3]. - Historical data shows that disperse dye prices reached a high of 45,000 yuan/ton in 2015 and 19,000 yuan/ton currently, while active dye prices peaked at 33,000 yuan/ton in 2016 and are now at 23,000 yuan/ton, indicating substantial upward price potential [3]. Investment Recommendations - Companies to watch include RunTu Co., Zhejiang Longsheng, Jihua Group, Jinji Co., Annuoqi, Yabang Co., Fulaient, Wanfeng Co., and Haixiang Pharmaceutical, which are expected to benefit from the favorable market dynamics and integrated advantages [3].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 证券停复牌情况：适用 因控股股东正在筹划控制权变更事项，该事项可能导致公司控制权发生变更，鉴于该事项存在不确定 性,本公司的相关证券停复牌情况如下： ■ 登录新浪财经APP 搜索【信披】查看更多考评等级 浙江吉华集团股份有限公司（以下简称"公司"）于2026年1月30日接到控股股东杭州锦辉机电设备有限 公司的通知，获悉杭州锦辉机电设备有限公司正在筹划有关协议转让所持有的公司部分股权等事宜，该 事项可能导致公司控股股东、实际控制人发生变更。 证券代码：603980 证券简称：吉华集团 公告编号：2026-006 浙江吉华集团股份有限公司 关于筹划控制权变更事项继续停牌的公告 停牌期间，公司将根据事项进展情况，严格按照法律法规的规定和要求履行信息披露义务。待上述事项 确定后，公司将及时发布相关公告并申请复牌。公司指定信息披露网站、媒体为上海证券交易所网站 （www.sse.com.cn）、《上海证券报》及《证券时报》，有关公司信息以公司在上述指定网站、媒体刊 登的 ...

摘要：中建投信托·安泉593号（青岛融创）集合资金信托计划是投向青岛融创地产项目的集合资金信托，因房企流动性危机导致逾期，2026年2月2日上市 公司吉华集团（5000万元认购方）实现全额兑付，成为地产信托风险化解的典型案例。 2026年2月2日，上市公司吉华集团发布公告，宣布其认购的中建投信托"安泉593号"信托产品实现全额兑付，累计收回本金5000万元、收益306.25万元。 这一消息，标志着这场持续3年4个月、牵扯融创债务危机的地产信托逾期事件，正式画上句号。作为地产下行周期中信托风险处置的典型案例，"安泉593 号"的始末的现状，不仅关乎投资者权益，更藏着地产信托风险化解的核心逻辑与行业启示。 一、产品始末：从成立到逾期，一场由房企危机引发的兑付拉锯 要读懂"安泉593号"的兑付故事，首先要回溯其核心背景——这款产品的命运，从诞生之初就与房地产市场的周期波动深度绑定。 1. 产品核心信息（关键要素一目了然） "安泉593号"全称为中建投信托·安泉593号（青岛融创）集合资金信托计划，成立于2021年2月9日，第四期认购日为2021年3月31日，原到期日为2022年9 月30日。 其核心要素清晰：融资方 ...

Group 1 - Fulin Precision's subsidiary Jiangxi Shenghua invested 270 million yuan to establish a joint venture for a 500,000-ton ferrous oxalate project, with a total investment of 1.5 billion yuan expected to be completed by September 30, 2026 [1] - Xuguang Electronics plans to raise up to 1 billion yuan through a private placement to fund high-voltage vacuum arc extinguishing chamber expansion and other projects [2] - Minexplosion Optoelectronics intends to acquire 100% equity of Xiazhi Precision, with the transaction subject to shareholder and regulatory approvals [3] Group 2 - Shangluo Electronics' controlling shareholder plans to reduce his stake by up to 3% due to personal financial needs [4] - Babi Food reported a 1.3% decline in net profit for 2025, despite an 11.22% increase in revenue [5] - Pengding Holdings' subsidiary acquired industrial land in Huai'an for 66.14 million yuan [6] Group 3 - Zhuoyue New Energy's net profit for 2025 increased by 14.16%, despite a 17.43% decline in revenue [7] - Zhongyuan Media's net profit grew by 30.99% in 2025, with revenue decreasing by 5.13% [8] - Huangshan Tourism plans to invest approximately 530 million yuan in a hotel project with a 24-month construction period [9] Group 4 - *ST Jinling's restructuring plan was approved by the court, which may improve the company's financial situation [11] - Jichuan Pharmaceutical's subsidiary paid 80 million yuan for exclusive commercialization rights of a drug [12] - Pilin Bio's subsidiary received a notice for the acceptance of a drug supplement application [13] Group 5 - Nepe Mining terminated its investment in Swiss Veritas Resources AG due to changes in conditions [14] - Jinhui Wine announced a cash dividend of 0.20 yuan per share for the first three quarters of 2025 [15] - Hualan Biological's clinical trial for a new drug received approval for an additional indication [16] Group 6 - Industrial Fulian reported a total of 247 million yuan spent on share buybacks as of January 31, 2026 [17] - Yitong Century was pre-selected for a 107 million yuan project with China Tower [18] - Wanfeng Co. noted uncertainty in future price changes for disperse dyes [19] Group 7 - Bibet's clinical trial application for a new drug was approved by the National Medical Products Administration [21] - Chengbang Co. signed new project contracts worth 40.03 million yuan in Q4 2025 [22] - *ST Hengji received a court ruling for a performance compensation of 175 million yuan [23] Group 8 - Jihua Group is planning a change in control, leading to continued stock suspension [24] - Ningbo Port expects a container throughput of 5.03 million TEUs in January 2026, a 9.5% increase [25] - Hengli Petrochemical's actual controller increased his stake by 3.3 million shares [26] Group 9 - Hongfuhan signed a sales contract worth 480 million yuan with Guangdong Quanxiang [27] - All New Good's shareholder lifted a judicial freeze on 4.36% of the company's shares [28] - Changchun High-tech's subsidiary's clinical trial application for a new drug was accepted [29] Group 10 - Xingqi Eye Medicine's clinical trial for a new drug entered the first/second phase [31] - Hanma Technology reported a 140.04% increase in new energy heavy truck production in January 2026 [32] - Hengfeng Paper plans to invest 349 million yuan in a new green printing project [33] Group 11 - Zhifei Biological's mRNA vaccine for shingles received clinical trial approval [34] - Yutong Bus reported a 15.35% decrease in production in January 2026 [35] - StarNet Ruijie plans to sign a lease contract with an affiliate for a total rent of up to 110 million yuan [36] Group 12 - Hacheng Bonda's director completed a 0.97% share reduction [37] - Hendi Pharmaceutical's application for a new drug was approved [38] - Xinhua Medical's subsidiary received a medical device registration certificate [40] Group 13 - Yaokang Bio reported a 31.49% increase in net profit for 2025 [41] - Gaotie Electric reported a 14.02% increase in net profit for 2025 [42]

吉华集团（603980）(603980.SH)发布公告，公司于2026年1月30日接到控股股东杭州锦辉机电设备有限 公司的通知，获悉杭州锦辉机电设备有限公司正在筹划有关协议转让所持有的公司部分股权等事宜，该 事项可能导致公司控股股东、实际控制人发生变更。公司股票已于2月2日开市起停牌。 截至公告披露日，相关各方正在积极推进本次交易的各项工作，整体方案仍在协商，交易各方尚未签署 正式协议，公司预计无法在2026年2月4日(星期三)开市起复牌，鉴于上述事项尚在筹划中，存在不确定 性。为保证公平信息披露，避免公司股价异常波动，维护广大投资者利益。根据相关规定，经公司向上 海证券交易所申请，公司股票将于2026年2月4日(星期三)开市起继续停牌，预计继续停牌时间不超过3 个交易日。 ...

重要内容提示： 证券停复牌情况：适用 因控股股东正在筹划控制权变更事项，该事项可能导致公司控制权发生变更， 鉴于该事项存在不确定性,本公司的相关证券停复牌情况如下： 证券代码：603980 证券简称：吉华集团 公告编号：2026-006 浙江吉华集团股份有限公司 关于筹划控制权变更事项继续停牌的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 停牌期间，公司将根据事项进展情况，严格按照法律法规的规定和要求履行 信息披露义务。待上述事项确定后，公司将及时发布相关公告并申请复牌。公司 指定信息披露网站、媒体为上海证券交易所网站（www.sse.com.cn）、《上海证券 报》及《证券时报》，有关公司信息以公司在上述指定网站、媒体刊登的公告为准。 敬请广大投资者注意投资风险。 特此公告。 浙江吉华集团股份有限公司董事会 2026 年 2 月 4 日 | 证券代码 | 证券简称 | 停复牌类型 | | 停牌起始日 | 停牌期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- ...

每经AI快讯，吉华集团公告，公司于2026年1月30日接到控股股东杭州锦辉机电设备有限公司的通知， 获悉杭州锦辉机电设备有限公司正在筹划有关协议转让所持有的公司部分股权等事宜，该事项可能导致 公司控股股东、实际控制人发生变更。截至本公告披露日，相关各方正在积极推进本次交易的各项工 作，整体方案仍在协商，交易各方尚未签署正式协议，公司预计无法在2026年2月4日（星期三）开市起 复牌，鉴于上述事项尚在筹划中，存在不确定性。公司向上海证券交易所申请，公司股票将于2026年2 月4日（星期三）开市起继续停牌，预计继续停牌时间不超过3个交易日。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 格隆汇2月3日丨吉华集团(603980.SH)公布，截至本公告披露日，相关各方正在积极推进本次交易的各 项工作，整体方案仍在协商，交易各方尚未签署正式协议，公司预计无法在2026年2月4日（星期三）开 市起复牌，鉴于上述事项尚在筹划中，存在不确定性。为保证公平信息披露，避免公司股价异常波动， 维护广大投资者利益。根据相关规定，经公司向上海证券交易所申请，公司股票将于2026年2月4日（星 期三）开市起继续停牌，预计继续停牌时间不超过3个交易日。 ...

格隆汇2月3日丨吉华集团(603980.SH)公布，截至本公告披露日，相关各方正在积极推进本次交易的各 项工作，整体方案仍在协商，交易各方尚未签署正式协议，公司预计无法在2026年2月4日（星期三）开 市起复牌，鉴于上述事项尚在筹划中，存在不确定性。为保证公平信息披露，避免公司股价异常波动， 维护广大投资者利益。根据相关规定，经公司向上海证券交易所申请，公司股票将于2026年2月4日（星 期三）开市起继续停牌，预计继续停牌时间不超过3个交易日。 ...

吉华集团公告称，1月30日控股股东杭州锦辉机电正在筹划协议转让部分公司股权，或致公司控股股 东、实控人变更。2月2日起公司股票停牌。截至公告披露日，方案仍在协商，未签正式协议，预计无法 于2月4日复牌。公司申请股票2月4日开市起继续停牌，预计不超3个交易日。停牌期间将及时披露进 展，事项确定后申请复牌。 ...